MyMyelomaTeam

IVIG (intravenous immunoglobulin) isn't a primary treatment for myeloma itself, but it plays a meaningful supportive role. Because myeloma and its treatments can weaken the immune system, IVIG helps by supplementing antibodies that the body isn't producing enough of on its own. It falls under the category of supportive Show Full Answer

IVIG (intravenous immunoglobulin) isn't a primary treatment for myeloma itself, but it plays a meaningful supportive role. Because myeloma and its treatments can weaken the immune system, IVIG helps by supplementing antibodies that the body isn't producing enough of on its own. It falls under the category of supportive care, which focuses on:

- Reducing the severity of side effects
- Improving day-to-day functioning
- Supporting overall quality of life

So while IVIG won't target myeloma cells directly, it can be an important piece of the puzzle — especially for managing infection risk, which is a real concern for many people living with myeloma.

It's always worth asking your care team whether IVIG is appropriate for your specific situation, as supportive treatments are tailored to each person's needs.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

12 Myeloma Treatment Options